Status:
COMPLETED
Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome
Lead Sponsor:
Hormozgan University of Medical Sciences
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory infertility and causes menstrual disruption in 6.6-6.8% of women in reproductive age and is characterized by insulin resistan...
Detailed Description
Poly cystic ovarian syndrome (PCOS) is a common hormonal disorder in women that affecting of 6.6-6.8% of women o f reproductive age. PCOS associated with a broad range of clinical, hormonal and metabo...
Eligibility Criteria
Inclusion
- Women with PCOS
Exclusion
- avoiding to participate in the study
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01474967
Start Date
February 1 2010
End Date
February 1 2011
Last Update
November 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hormozgan University of Medical Sciences (HUMS)
Bandarabbas, Hormozgan, Iran, 791451692